4//SEC Filing
Ho Robert 4
Accession 0001209191-21-049923
CIK 0001404644other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:14 PM ET
Size
5.6 KB
Accession
0001209191-21-049923
Insider Transaction Report
Form 4
Ho Robert
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-03+190,000→ 190,000 totalExercise: $6.80Exp: 2031-08-03→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total shares on August 3, 2022, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001806254
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:14 PM ET
- Size
- 5.6 KB